{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:11:42Z","timestamp":1791544302221,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Nature Science Foundation of Henan Province","doi-asserted-by":"crossref","award":["182300410365"],"award-info":[{"award-number":["182300410365"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triglyceride-glucose body mass index (TyG-BMI) is an emerging surrogate indicator of insulin resistance adiposity, which has been demonstrated as a risk factor for various cardiovascular diseases including hypertension, and myocardial infarction. However, association of TyG-BMI with incident VTE remains to be investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 328,208 participants from the prospective UK Biobank cohort without baseline VTE. The primary outcome was incident VTE, and the second outcomes were incident pulmonary embolism (PE) and deep vein thrombosis (DVT). Multivariable-adjusted Cox proportional hazards regression and restricted cubic spline (RCS) analyses assessed the association between baseline TyG-BMI and incident VTE. Stratified analyses evaluated potential effect modification by age, sex, smoking, alcohol use, diabetes, hypertension, cancer, BMI, physical activity, and dietary quality. In addition, we estimated population attributable fractions (PAFs) for elevated TyG-BMI (quartiles above quartile 1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a median follow-up of 13.64\u00a0years, 8353 VTE events occurred. VTE incidence rose from 114.0 to 279.1 per 100,000 person-years across TyG-BMI quartiles. After full multivariable adjustment, the highest had elevated risks of VTE (HR 2.10, 95% CI 1.94\u20132.26), PE (HR 2.28, 95% CI 2.06\u20132.52), and DVT (HR 1.88, 95% CI 1.66\u20132.12) compared with the lowest quartile. Risk rose sharply and non-linearly beyond a TyG-BMI threshold of 231.9. Associations were stronger among women, younger participants (&lt;\u200960\u00a0years), non-smokers, and individuals not on lipid-lowering therapy, and remained robust in sensitivity analyses. The PAF for VTE was 0.333 (95% CI 0.295\u20130.371), for PE 0.376 (0.328\u20130.419), and for DVT 0.276 (0.212\u20130.341).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher TyG-BMI independently predicts increased risk of first-ever VTE, underscoring its utility as a composite biomarker for identifying individuals at heightened thrombotic risk related to metabolic dysfunction and obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-025-03824-5","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:36:14Z","timestamp":1768012574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Triglyceride-glucose body mass index and risk of incident venous thromboembolism: a prospective cohort study from the UK Biobank"],"prefix":"10.1186","volume":"31","author":[{"given":"Shen-Shen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai-Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Jiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Qing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Jie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Min","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"8","key":"3824_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","volume":"12","author":"JA Heit","year":"2015","unstructured":"Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464\u201374.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"3824_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","volume":"20","author":"PL Lutsey","year":"2023","unstructured":"Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023;20(4):248\u201362.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"3824_CR3","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2025;151(8):e41\u2013660.","journal-title":"Circulation"},{"key":"3824_CR4","volume":"54","author":"K Zhen","year":"2025","unstructured":"Zhen K, Tao Y, Xia L, Wang S, Gao Q, Wang D, et al. Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study. Lancet Reg Health West Pac. 2025;54:101258.","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"3824_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/ATVBAHA.124.320151","volume":"44","author":"A Wendelboe","year":"2024","unstructured":"Wendelboe A, Weitz JI. Global health burden of venous thromboembolism. Arterioscler Thromb Vasc Biol. 2024;44(5):1007\u201311.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"3824_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.beha.2012.06.007","volume":"25","author":"SZ Goldhaber","year":"2012","unstructured":"Goldhaber SZ. Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol. 2012;25(3):235\u201342.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"23 Suppl 1","key":"3824_CR7","first-page":"I9","volume":"107","author":"FA Anderson Jr.","year":"2003","unstructured":"Anderson FA Jr., Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9-16.","journal-title":"Circulation"},{"issue":"1","key":"3824_CR8","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.amepre.2021.12.023","volume":"63","author":"KO Weze","year":"2022","unstructured":"Weze KO, Obisesan OH, Dardari ZA, Cainzos-Achirica M, Dzaye O, Graham G, et al. The interplay of race\/ethnicity and obesity on the incidence of venous thromboembolism. Am J Prev Med. 2022;63(1):e11\u201320.","journal-title":"Am J Prev Med"},{"issue":"2","key":"3824_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","volume":"4","author":"J Gregson","year":"2019","unstructured":"Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol. 2019;4(2):163\u201373.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"3824_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3324\/haematol.10828","volume":"92","author":"C Ay","year":"2007","unstructured":"Ay C, Tengler T, Vormittag R, Simanek R, Dorda W, Vukovich T, et al. Venous thromboembolism\u2013a manifestation of the metabolic syndrome. Haematologica. 2007;92(3):374\u201380.","journal-title":"Haematologica"},{"issue":"5","key":"3824_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1538-7836.2008.03234.x","volume":"7","author":"KH Borch","year":"2009","unstructured":"Borch KH, Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromso study. J Thromb Haemost. 2009;7(5):739\u201345.","journal-title":"J Thromb Haemost"},{"key":"3824_CR12","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa004","author":"M Bluher","year":"2020","unstructured":"Bluher M. Metabolically healthy obesity. Endocr Rev. 2020. https:\/\/doi.org\/10.1210\/endrev\/bnaa004.","journal-title":"Endocr Rev"},{"issue":"6","key":"3824_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1538-7836.2012.04707.x","volume":"10","author":"IM Van Schouwenburg","year":"2012","unstructured":"Van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Bakker SJ, Kluin-Nelemans HC, Meijer K, et al. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost. 2012;10(6):1012\u20138.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3824_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01971-9","volume":"22","author":"Z Yang","year":"2023","unstructured":"Yang Z, Gong H, Kan F, Ji N. Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3824_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3824_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.","journal-title":"PLoS ONE"},{"issue":"1","key":"3824_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-023-01954-5","volume":"22","author":"M Wang","year":"2023","unstructured":"Wang M, Chang M, Shen P, Wei W, Li H, Shen G. Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease. Lipids Health Dis. 2023;22(1):186.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3824_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01411-5","volume":"23","author":"HR Nikbakht","year":"2023","unstructured":"Nikbakht HR, Najafi F, Shakiba E, Darbandi M, Navabi J, Pasdar Y. Triglyceride glucose-body mass index and hypertension risk in Iranian adults: a population-based study. BMC Endocr Disord. 2023;23(1):156.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"3824_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01898-1","volume":"22","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):161.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3824_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/jth.12825","volume":"13","author":"C Ay","year":"2015","unstructured":"Ay C, Posch F, Kaider A, Zielinski C, Pabinger I. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality. J Thromb Haemost. 2015;13(3):390\u20137.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3824_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14741","volume":"6","author":"N Rassy","year":"2023","unstructured":"Rassy N, Van Straaten A, Carette C, Hamer M, Rives-Lange C, Czernichow S. Association of healthy lifestyle factors and obesity-related diseases in adults in the UK. JAMA Netw Open. 2023;6(5):e2314741.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"3824_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586\u2013613.","journal-title":"Circulation"},{"issue":"2","key":"3824_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/09622802241287707","volume":"34","author":"PC Austin","year":"2025","unstructured":"Austin PC. Graphical methods to illustrate the nature of the relation between a continuous variable and the outcome when using restricted cubic splines with a Cox proportional hazards model. Stat Methods Med Res. 2025;34(2):277\u201385.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"3824_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/ije\/dyz212","volume":"49","author":"T Strain","year":"2020","unstructured":"Strain T, Wijndaele K, Sharp SJ, Dempsey PC, Wareham N, Brage S. Impact of follow-up time and analytical approaches to account for reverse causality on the association between physical activity and health outcomes in UK Biobank. Int J Epidemiol. 2020;49(1):162\u201372.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"3824_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2307\/2532206","volume":"49","author":"S Greenland","year":"1993","unstructured":"Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics. 1993;49(3):865\u201372.","journal-title":"Biometrics"},{"key":"3824_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.587","author":"JM Rivera-Caravaca","year":"2024","unstructured":"Rivera-Caravaca JM, Soler-Espejo E, Gonzalez-Lozano E, Lip GYH, Marin F, Roldan V. The triglyceride-glucose index is a marker of thromboembolic events in atrial fibrillation patient under oral anticoagulation therapy. Eur Heart J. 2024. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.587.","journal-title":"Eur Heart J"},{"issue":"1","key":"3824_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01923-1","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, Huang L, Li F. A nomogram based on the TyG index for the prediction of lower-limb venous thrombosis in patients with intracerebral hemorrhage. Sci Rep. 2025;15(1):17406.","journal-title":"Sci Rep"},{"issue":"3","key":"3824_CR28","first-page":"593","volume":"110","author":"A Delluc","year":"2013","unstructured":"Delluc A, De Moreuil C, Kerspern H, Le Moigne E, Mottier D, Tromeur C, et al. Body mass index, a major confounder to insulin resistance association with unprovoked venous thromboembolism. Results from the EDITH case-control study. Thromb Haemost. 2013;110(3):593\u20137.","journal-title":"Thromb Haemost"},{"issue":"11","key":"3824_CR29","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/ATVBAHA.114.304085","volume":"34","author":"W Ageno","year":"2014","unstructured":"Ageno W, Di Minno MN, Ay C, Jang MJ, Hansen JB, Steffen LM, et al. Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. Arterioscler Thromb Vasc Biol. 2014;34(11):2478\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3824_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3824_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3824_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1\u20134.","journal-title":"J Clin Invest"},{"key":"3824_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.07.027","volume":"309","author":"E Oikonomou","year":"2020","unstructured":"Oikonomou E, Leopoulou M, Theofilis P, Antonopoulos AS, Siasos G, Latsios G, et al. A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: clinical and therapeutic implications. Atherosclerosis. 2020;309:16\u201326.","journal-title":"Atherosclerosis"},{"key":"3824_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2020.115630","volume":"267","author":"H Tang","year":"2020","unstructured":"Tang H, Cheng Z, Li N, Mao S, Ma R, He H, et al. The short- and long-term associations of particulate matter with inflammation and blood coagulation markers: a meta-analysis. Environ Pollut. 2020;267:115630.","journal-title":"Environ Pollut"},{"issue":"12","key":"3824_CR35","first-page":"15919","volume":"8","author":"S Bilgic Gazioglu","year":"2015","unstructured":"Bilgic Gazioglu S, Akan G, Atalar F, Erten G. PAI-1 and TNF-alpha profiles of adipose tissue in obese cardiovascular disease patients. Int J Clin Exp Pathol. 2015;8(12):15919\u201325.","journal-title":"Int J Clin Exp Pathol"},{"key":"3824_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063170","author":"R Altalhi","year":"2021","unstructured":"Altalhi R, Pechlivani N, Ajjan RA. PAI-1 in diabetes: pathophysiology and role as a therapeutic target. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22063170.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3824_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-012-9229-1","volume":"14","author":"R Muniyappa","year":"2013","unstructured":"Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord. 2013;14(1):5\u201312.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"3824_CR38","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1113\/JP275856","volume":"597","author":"C Willson","year":"2019","unstructured":"Willson C, Watanabe M, Tsuji-Hosokawa A, Makino A. Pulmonary vascular dysfunction in metabolic syndrome. J Physiol. 2019;597(4):1121\u201341.","journal-title":"J Physiol"},{"issue":"13","key":"3824_CR39","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2174\/1381612811319130010","volume":"19","author":"S Del Turco","year":"2013","unstructured":"Del Turco S, Gaggini M, Daniele G, Basta G, Folli F, Sicari R, et al. Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk. Curr Pharm Des. 2013;19(13):2420\u201331.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"3824_CR40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1538-7836.2009.03295.x","volume":"7","author":"LM Steffen","year":"2009","unstructured":"Steffen LM, Cushman M, Peacock JM, Heckbert SR, Jacobs DR Jr., Rosamond WD, et al. Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism etiology. J Thromb Haemost. 2009;7(5):746\u201351.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"3824_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001515","volume":"10","author":"YJ Cheng","year":"2013","unstructured":"Cheng YJ, Liu ZH, Yao FJ, Zeng WT, Zheng DD, Dong YG, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013;10(9):e1001515.","journal-title":"PLoS Med"},{"issue":"8","key":"3824_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1055\/s-0044-1781425","volume":"124","author":"HC Du","year":"2024","unstructured":"Du HC, Zheng YF, Shen MQ, Deng BY. No genetic causality between tobacco smoking and venous thromboembolism: a two-sample Mendelian randomization study. Thromb Haemost. 2024;124(8):795\u2013802.","journal-title":"Thromb Haemost"},{"issue":"35","key":"3824_CR43","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1093\/eurheartj\/ehae361","volume":"45","author":"IT Farmakis","year":"2024","unstructured":"Farmakis IT, Christodoulou KC, Hobohm L, Konstantinides SV, Valerio L. Lipid lowering for prevention of venous thromboembolism: a network meta-analysis. Eur Heart J. 2024;45(35):3219\u201327.","journal-title":"Eur Heart J"},{"issue":"11","key":"3824_CR44","volume":"11","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang P, Tian J, Zhang P, Yang K, Li L. Statins for the primary prevention of venous thromboembolism. Cochrane Database Syst Rev. 2024;11(11):CD014769.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3824_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0043-1772212","volume":"124","author":"T Frischmuth","year":"2024","unstructured":"Frischmuth T, Tondel BG, Braekkan SK, Hansen JB, Morelli VM. The risk of incident venous thromboembolism attributed to overweight and obesity: the Tromso study. Thromb Haemost. 2024;124(3):239\u201349.","journal-title":"Thromb Haemost"},{"issue":"1","key":"3824_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2401112","volume":"56","author":"Z Cao","year":"2024","unstructured":"Cao Z, Jiang X, He Y, Zheng X. Metabolic landscape in venous thrombosis: insights into molecular biology and therapeutic implications. Ann Med. 2024;56(1):2401112.","journal-title":"Ann Med"},{"issue":"4","key":"3824_CR47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.thromres.2015.01.012","volume":"135","author":"KM Sanfilippo","year":"2015","unstructured":"Sanfilippo KM, Wang TF, Gage BF, Liu W, Carson KR. Improving accuracy of International classification of diseases codes for venous thromboembolism in administrative data. Thromb Res. 2015;135(4):616\u201320.","journal-title":"Thromb Res"},{"issue":"12","key":"3824_CR48","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1097\/MLR.0000000000000524","volume":"55","author":"MC Fang","year":"2017","unstructured":"Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, et al. Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: the CVRN VTE study. Med Care. 2017;55(12):e137\u201343.","journal-title":"Med Care"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03824-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:02:38Z","timestamp":1770397358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03824-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3824"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03824-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The consents were approved and electronically signed by all participants in the study. The ethical approval was obtained from the NHS North West Centre for Research Ethics Committee (No. 11\/NW\/03820).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}